Artelo Biosciences Q3 2024 Lipid Signaling Investor Presentation

Artelo Biosciences is a clinical-stage biopharmaceutical company developing a lipid signaling modulation platform to address pain, cancer, anxiety, depression, and other conditions. The presentation highlights the company's novel science, drug pipeline, near-term catalysts, and robust patent estate across billion-dollar market opportunities.